Evidence map›Paper›PMID 34360670›Full record

ArticleInternational journal of molecular sciences2021

Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury.

Grigorios Christidis, Ersin Karatayli, Rabea A Hall, Susanne N Weber, Matthias C Reichert, Mathias Hohl, Sen Qiao, Ulrich Boehm, Dieter Lütjohann, Frank Lammert and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Prospect of Animal Models for Acute-on-chronic Liver Failure: A Mini-review.Journal of clinical and translational hepatology · 2022
    Review
  7. Review
  8. Emerging roles of fibroblast growth factor 21 in critical disease.Frontiers in cardiovascular medicine · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Grigorios ChristidisDepartment of Medicine II, Saarland University Medical Center, Saarland University, 66421 Homburg, Germany.
Ersin KaratayliDepartment of Medicine II, Saarland University Medical Center, Saarland University, 66421 Homburg, Germany.
Rabea A HallDepartment of Medicine II, Saarland University Medical Center, Saarland University, 66421 Homburg, Germany.
Susanne N WeberDepartment of Medicine II, Saarland University Medical Center, Saarland University, 66421 Homburg, Germany.
Matthias C ReichertDepartment of Medicine II, Saarland University Medical Center, Saarland University, 66421 Homburg, Germany.ORCID 0000-0002-8192-0575
Mathias HohlDepartment of Medicine III, Saarland University Medical Center, Saarland University, 66421 Homburg, Germany.ORCID 0000-0001-6946-9825
Sen QiaoDepartment of Pharmacology and Toxicology, Saarland University Medical Center, Saarland University, 66421 Homburg, Germany.
Ulrich BoehmDepartment of Pharmacology and Toxicology, Saarland University Medical Center, Saarland University, 66421 Homburg, Germany.
Dieter LütjohannInstitute of Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, 53127 Bonn, Germany.ORCID 0000-0002-7941-8308
Frank LammertDepartment of Medicine II, Saarland University Medical Center, Saarland University, 66421 Homburg, Germany.ORCID 0000-0003-4450-7201
Senem Ceren KaratayliDepartment of Medicine II, Saarland University Medical Center, Saarland University, 66421 Homburg, Germany.
Saarland University · DEMedizinische Hochschule Hannover · DEUniversity Hospital Bonn · DE

Funding

Bundesministerium für Bildung, Wissenschaft und Forschung LiSyM 031L0051
6 · The paper itself

Abstract

BACKGROUND AND

aimsFibroblast growth factor (FGF) 21 has recently been shown to play a potential role in bile acid metabolism. We aimed to investigate the FGF21 response in an ethanol-induced acute-on-chronic liver injury (ACLI) model in

methodsTotal RNA was extracted from wild-type (WT, C57BL/6J) and

resultsAlcohol feeding significantly induced plasma FGF21 and decreased hepatic

conclusionsThe simultaneous upregulation of FGF21 and downregulation of

Indexed as

Acute-On-Chronic Liver FailureAnimalsATP-Binding Cassette Sub-Family B Member 4ATP Binding Cassette Transporter, Subfamily BBile Acids and SaltsCase-Control StudiesCholesterol 7-alpha-HydroxylaseFemaleFibroblast Growth FactorsHepatocytesMaleMiceMice, Inbred C57BLMice, KnockoutReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearATP-Binding Cassette Sub-Family B Member 4ATP Binding Cassette Transporter, Subfamily BBile Acids and SaltsCholesterol 7-alpha-Hydroxylasefibroblast growth factor 21Fibroblast Growth FactorsReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and Nuclearacute-on-chronic liver failure (ACLF)alcohol-associated liver disease (AALD)ATP binding cassette subfamily B member 4 (Abcb4) knock-out mousebile acidcholesterol 7α-hydroxylase (Cyp7A1)fibroblast growth factor 21 (FGF21)

Identifiers

PMID34360670
PMCPMC8348955
OpenAlexW3183312290

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.